● Recruiting

68Ga-Pentixafor PET/CT Versus Adrenal Vein Sampling in Diagnosing Unilateral Subtype of Primary Aldosteronism Concurrent With Autonomous Cortisol Secretion (PREDICT)

Condition: Primary Aldosteronism · Autonomous Cortisol Secretion · Sponsor: Qifu Li

PhaseNA

Planned participants178

Who can joinAll sexes, 18 Years to 70 Years

Healthy volunteersNo

About this study

To validate the accuracy of 68Ga-Pentixafor PET/CT and adrenal venous sampling (AVS) in subtype diagnosis of PA/ACS patients with adrenal nodules, based on biochemical and clinical remission outcomes, and to determine whether the diagnostic accuracy of 68Ga-Pentixafor PET/CT is non-inferior to AVS.

This description comes directly from the study's public registry record.

Talk to the study team

Qifu Li · +86 023-89011552 · liqifu@yeah.net

Always discuss trial participation with your own doctor first.

Locations (1)

The First Affilated Hospital of Chongqing Medical University

Chongqing, Chongqing Municipality, China

Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06833437